Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 21% ± 3% | |
astrocyte | 5 studies | 25% ± 8% | |
glutamatergic neuron | 4 studies | 32% ± 11% | |
oligodendrocyte | 4 studies | 20% ± 2% | |
epithelial cell | 3 studies | 20% ± 3% | |
GABAergic neuron | 3 studies | 37% ± 5% | |
microglial cell | 3 studies | 19% ± 2% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 4% | |
goblet cell | 3 studies | 25% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 30% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 598.38 | 459 / 459 | 99% | 11.00 | 1106 / 1118 |
brain | 99% | 323.23 | 2617 / 2642 | 100% | 11.87 | 703 / 705 |
lung | 99% | 445.02 | 571 / 578 | 99% | 8.17 | 1145 / 1155 |
thymus | 100% | 520.00 | 653 / 653 | 98% | 8.64 | 592 / 605 |
esophagus | 100% | 506.57 | 1445 / 1445 | 97% | 7.08 | 178 / 183 |
ovary | 100% | 731.97 | 180 / 180 | 97% | 6.48 | 418 / 430 |
uterus | 100% | 740.11 | 170 / 170 | 97% | 9.25 | 443 / 459 |
bladder | 100% | 626.38 | 21 / 21 | 96% | 7.43 | 486 / 504 |
prostate | 100% | 489.21 | 244 / 245 | 97% | 8.10 | 486 / 502 |
stomach | 100% | 398.61 | 359 / 359 | 96% | 6.19 | 274 / 286 |
pancreas | 97% | 225.99 | 317 / 328 | 98% | 6.85 | 175 / 178 |
intestine | 100% | 619.07 | 966 / 966 | 95% | 6.65 | 500 / 527 |
kidney | 100% | 328.25 | 89 / 89 | 95% | 7.02 | 854 / 901 |
skin | 100% | 558.22 | 1805 / 1809 | 94% | 8.93 | 445 / 472 |
adrenal gland | 99% | 463.42 | 255 / 258 | 92% | 8.23 | 212 / 230 |
liver | 96% | 190.25 | 217 / 226 | 80% | 4.04 | 324 / 406 |
spleen | 100% | 547.92 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.09 | 1 / 1 |
blood vessel | 100% | 587.45 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 567.98 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 274.76 | 789 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 319.46 | 833 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 6.05 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 8.99 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 80% | 4.72 | 64 / 80 |
peripheral blood | 61% | 222.99 | 567 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009411 | Biological process | response to UV |
GO_0031297 | Biological process | replication fork processing |
GO_0019985 | Biological process | translesion synthesis |
GO_0042276 | Biological process | error-prone translesion synthesis |
GO_0043504 | Biological process | mitochondrial DNA repair |
GO_0062176 | Biological process | R-loop processing |
GO_0006264 | Biological process | mitochondrial DNA replication |
GO_0006269 | Biological process | DNA replication, synthesis of primer |
GO_0000428 | Cellular component | DNA-directed RNA polymerase complex |
GO_0005657 | Cellular component | replication fork |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005634 | Cellular component | nucleus |
GO_0030145 | Molecular function | manganese ion binding |
GO_0003887 | Molecular function | DNA-directed DNA polymerase activity |
GO_0003896 | Molecular function | DNA primase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | PRIMPOL |
Protein name | DNA-directed primase/polymerase protein DNA-directed primase/polymerase protein (hPrimpol1) (EC 2.7.7.-) (Coiled-coil domain-containing protein 111) |
Synonyms | FLJ33167 hCG_1786938 CCDC111 |
Description | FUNCTION: DNA primase and DNA polymerase required to tolerate replication-stalling lesions by bypassing them . Required to facilitate mitochondrial and nuclear replication fork progression by initiating de novo DNA synthesis using dNTPs and acting as an error-prone DNA polymerase able to bypass certain DNA lesions . Shows a high capacity to tolerate DNA damage lesions such as 8oxoG and abasic sites in DNA . Provides different translesion synthesis alternatives when DNA replication is stalled: able to synthesize DNA primers downstream of lesions, such as ultraviolet (UV) lesions, R-loops and G-quadruplexes, to allow DNA replication to continue . Can also realign primers ahead of 'unreadable lesions' such as abasic sites and 6-4 photoproduct (6-4 pyrimidine-pyrimidinone), thereby skipping the lesion . Also able to incorporate nucleotides opposite DNA lesions such as 8oxoG, like a regular translesion synthesis DNA polymerase . Also required for reinitiating stalled forks after UV damage during nuclear DNA replication . Required for mitochondrial DNA (mtDNA) synthesis and replication, by reinitiating synthesis after UV damage or in the presence of chain-terminating nucleotides . Prevents APOBEC family-mediated DNA mutagenesis by repriming downstream of abasic site to prohibit error-prone translesion synthesis (By similarity). Has non-overlapping function with POLH . In addition to its role in DNA damage response, also required to maintain efficient nuclear and mitochondrial DNA replication in unperturbed cells . .; FUNCTION: Involved in adaptive response to cisplatin, a chemotherapeutic that causes reversal of replication forks, in cancer cells: reinitiates DNA synthesis past DNA lesions in BRCA1-deficient cancer cells treated with cisplatin via its de novo priming activity . Repriming rescues fork degradation while leading to accumulation of internal ssDNA gaps behind the forks . ATR regulates adaptive response to cisplatin . . |
Accessions | ENST00000503752.5 [Q96LW4-1] D6R908 ENST00000508001.1 ENST00000515152.1 ENST00000509002.5 ENST00000506278.5 Q96LW4 ENST00000515774.5 ENST00000314970.11 [Q96LW4-1] H0Y9N8 A0A5S6SZ32 D6R971 ENST00000512834.5 [Q96LW4-2] |